A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Acarizax is a prescription immunotherapy drug that is used to reduce allergic reactions of a person to American dust mites and European dust mites. The tablets contain standardized allergen extract from dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus.
Acarizax is used for the treatment of patients with IgE-mediated allergy symptoms. It works by causing an antibody response with an increase in IgG, which then competes with IgE in the binding to allergens, which reduces the immune response.
The treatment typically begins working in about four weeks.
The usual dosage is one tablet by mouth once daily. Your prescriber may modify the dosage.
The tablet is a sublingual tablet that should be placed under the tongue and allowed to dissolve. Do not chew or swallow the tablet. Remove the tablet from the blister pack with dry fingers and place it under the tongue immediately.
Do not eat or drink anything for five minutes after administration.
The active ingredient in Acarizax is an allergen extract from house dust mites (HDM).
There are no known significant interactions.
The effects may take 8-14 weeks to become apparent after starting treatment. If there is no effect after one year, then treatment should be stopped.
Acarizax is not recommended for patients under 18 years of age for allergic asthma or under 12 years of age for allergic rhinitis.
The most common side effects may include:
Acarizax [package insert]. Australia: Seqirus Pty Ltd; 2022.